Enrollment Complete in Lipogems ARISE I Study
Lipogems completed enrollment in the ARISE I FDA IDE study examining MicroFat vs. corticosteriod injection for the treatment of knee...
Lipogems completed enrollment in the ARISE I FDA IDE study examining MicroFat vs. corticosteriod injection for the treatment of knee...
The first patient is enrolled in ARISE II, an IDE research study to examine investigational MicroFat vs. saline injection to...
GID BIO completed enrollment for the first of two pivotal Phase III studies to investigate the use of your own...
BONESUPPORT's CERAMENT G is an orthopedic medical device combination matrix comprising a resorbable synthetic bone graft substitute and the antibiotic...
FDA granted 510(k) marketing clearance in the intervertebral disc space for Amplify Synthetic Bone Graft Putty....
HydroPutty bone graft features hydrophilic carriers designed to absorb fluids such as bone marrow aspirate, blood or saline....
CERAMENT bone void filler is an injectable, moldable and drillable synthetic bone void filler comprising hydroxyapatite and calcium sulfate....
The magnesium-based bone subsitute is cleared for use in the intervertebral body disc space, including cervical, thoracic and lumbar fusion....
Theradaptive gained FDA approval for their IDE submission to enroll patients into OASIS, a global Phase I/II Feasibility study in...
The proposed indication is an enhanced bioadhesive for reduction, provisional fixation or void filling of peri-articular fractures or defects....
As a guest member you get access to more articles and webinars every month.
We’ll send a recovery link to your email.
Return to Homepage